Kim, S., Jary, M., André, T., Vendrely, V., Buecher, B., François, E., . . . Borg, C. (2017). Docetaxel, Cisplatin, and 5-fluorouracil (DCF) chemotherapy in the treatment of metastatic or unresectable locally recurrent anal squamous cell carcinoma: A phase II study of French interdisciplinary GERCOR and FFCD groups (Epitopes-HPV02 study). BMC Cancer.
Chicago Stili AlıntıKim, Stefano, et al. "Docetaxel, Cisplatin, and 5-fluorouracil (DCF) Chemotherapy in the Treatment of Metastatic or Unresectable Locally Recurrent Anal Squamous Cell Carcinoma: A Phase II Study of French Interdisciplinary GERCOR and FFCD Groups (Epitopes-HPV02 Study)." BMC Cancer 2017.
MLA AlıntıKim, Stefano, et al. "Docetaxel, Cisplatin, and 5-fluorouracil (DCF) Chemotherapy in the Treatment of Metastatic or Unresectable Locally Recurrent Anal Squamous Cell Carcinoma: A Phase II Study of French Interdisciplinary GERCOR and FFCD Groups (Epitopes-HPV02 Study)." BMC Cancer 2017.